VTU Technology taking Pichia advances to CPhI Barcelona 2016

Grambach, Austria: Protein expression specialist VTU Technology will attend Europe’s largest pharmaceutical trade fair, CPhI 2016 in Barcelona in early October.

VTU will come to CPhI Worldwide in search of new partners and collaborators, offering its latest technology advances in exploiting its leading Pichia pastoris recombinant expression platform as well as out-licensing and co-development opportunities for several recombinant proteins.

New Pichia applications

The company’s Head of Business Development Dr. Thomas Purkarthofer, will represent VTU in Barcelona.

“We plan to use networking opportunities and face-to-face meetings to present latest advances and applications of our world-leading Pichia pastoris recombinant expression platform for higher efficiency production of a wide range of biologics and other recombinant proteins,” said Dr. Purkarthofer.

In addition, we’ll be able to talk about some very interesting new enhancements to VTU’s recently introduced glycoprotein production services – a combination of RCT´s Pichia GlycoSwitch® system boosted by VTU´s own Pichia pastoris platform for the production of tailored glycoproteins with human-like glycoforms,” Dr. Purkarthofer said.

“These provide fertile ground for productive partnerships for companies seeking competitive advantage,” he explained.

Astonishing protein yields

“Our experience over recent years has confirmed for us how important it is to meet our existing potential customers face to face,” said Dr. Purkarthofer.

“With the advances we’ve made during the past year, we can show them even an broader and more powerful Pichia pastoris protein production platform, with astonishing protein yields achieved in recent months,” he added.

About VTU Technology

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production enabling highest productivities delivering up to 25 g/L of secreted protein (record productivities of 35 g/L) within a few weeks development time.

VTU´s yield-enhancing Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression enhancing helper factors, several platform strains with different genetic backgrounds, elaborated cloning and transformation protocols, a high-throughput screening and cultivation regime combined with excellent know-how in fermentation and downstream process development for maximization of product yield and overall process performance.

Headquartered in Grambach, near Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma and life science as well as in the energy industries.

More information at: www.vtu-technology.com and www.vtu.com

About CPhI Worldwide 2016

CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitor opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.

Now in its 27th year, the 2016 fair is a three-day event opening October 4 at the Fira de Barcelona exhibition center. Last year’s event in Madrid attracted some 36,000 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.
The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

More information at: http://www.cphi.com/europe/